195 related articles for article (PubMed ID: 20427703)
1. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.
Leshchenko VV; Kuo PY; Shaknovich R; Yang DT; Gellen T; Petrich A; Yu Y; Remache Y; Weniger MA; Rafiq S; Suh KS; Goy A; Wilson W; Verma A; Braunschweig I; Muthusamy N; Kahl BS; Byrd JC; Wiestner A; Melnick A; Parekh S
Blood; 2010 Aug; 116(7):1025-34. PubMed ID: 20427703
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.
Enjuanes A; Albero R; Clot G; Navarro A; Beà S; Pinyol M; Martín-Subero JI; Klapper W; Staudt LM; Jaffe ES; Rimsza L; Braziel RM; Delabie J; Cook JR; Tubbs RR; Gascoyne R; Connors JM; Weisenburger DD; Greiner TC; Chan WC; López-Guillermo A; Rosenwald A; Ott G; Campo E; Jares P
Int J Cancer; 2013 Dec; 133(12):2852-63. PubMed ID: 23754783
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: transcriptional regulation by microRNAs.
Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
6. Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.
Enjuanes A; Fernàndez V; Hernández L; Navarro A; Beà S; Pinyol M; López-Guillermo A; Rosenwald A; Ott G; Campo E; Jares P
PLoS One; 2011; 6(5):e19736. PubMed ID: 21603610
[TBL] [Abstract][Full Text] [Related]
7. Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma.
Leshchenko VV; Kuo PY; Jiang Z; Weniger MA; Overbey J; Dunleavy K; Wilson WH; Wiestner A; Parekh S
Oncotarget; 2015 Sep; 6(29):27332-42. PubMed ID: 25714012
[TBL] [Abstract][Full Text] [Related]
8. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression.
Wang J; Xu H; Ge S; Xue C; Li H; Jing X; Liang K; Zhang X; Zhang C
Cancer Biol Med; 2021 Oct; 19(6):836-49. PubMed ID: 34633777
[TBL] [Abstract][Full Text] [Related]
9. Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.
Zhao X; Lapalombella R; Joshi T; Cheney C; Gowda A; Hayden-Ledbetter MS; Baum PR; Lin TS; Jarjoura D; Lehman A; Kussewitt D; Lee RJ; Caligiuri MA; Tridandapani S; Muthusamy N; Byrd JC
Blood; 2007 Oct; 110(7):2569-77. PubMed ID: 17440052
[TBL] [Abstract][Full Text] [Related]
10. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
[TBL] [Abstract][Full Text] [Related]
11. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
[TBL] [Abstract][Full Text] [Related]
12. Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma.
Alshareef A; Peters AC; Gélébart P; Chen W; Lai R
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477402
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways.
Rizzatti EG; Falcão RP; Panepucci RA; Proto-Siqueira R; Anselmo-Lima WT; Okamoto OK; Zago MA
Br J Haematol; 2005 Aug; 130(4):516-26. PubMed ID: 16098065
[TBL] [Abstract][Full Text] [Related]
15. Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma.
Neben K; Ott G; Schweizer S; Kalla J; Tews B; Katzenberger T; Hahn M; Rosenwald A; Ho AD; Müller-Hermelink HK; Lichter P; Krämer A
Int J Cancer; 2007 Apr; 120(8):1669-77. PubMed ID: 17236200
[TBL] [Abstract][Full Text] [Related]
16. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
18. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
[TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
[TBL] [Abstract][Full Text] [Related]
20. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
